Arkema (ARKAY)
(Delayed Data from OTC)
$105.64 USD
0.00 (0.00%)
Updated May 2, 2024 03:46 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Income Statements
Fiscal Year end for Arkema SA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 10,296 | 12,169 | 11,262 | 9,006 | 9,787 |
Cost Of Goods | NA | 9,451 | 8,727 | 7,238 | 7,657 |
Gross Profit | NA | 2,718 | 2,535 | 1,768 | 2,129 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 1,362 | 485 | 1,083 | 1,226 |
Income After Depreciation & Amortization | 0 | 1,356 | 2,050 | 685 | 903 |
Non-Operating Income | NA | -71 | -67 | -99 | -132 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | 1,285 | 1,983 | 586 | 771 |
Income Taxes | NA | 268 | 437 | 203 | 153 |
Minority Interest | NA | 1 | -2 | 3 | 9 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 452 | 1,018 | 1,546 | 383 | 617 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 452 | 1,017 | 1,549 | 379 | 608 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 2,101 | 3,017 | 1,540 | 1,631 |
Depreciation & Amortization (Cash Flow) | NA | 745 | 967 | 854 | 728 |
Income After Depreciation & Amortization | 0 | 1,356 | 2,050 | 685 | 903 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 77.99 | 74.42 | 75.86 | 83.84 | 84.71 |
Diluted EPS Before Non-Recurring Items | 9.47 | 16.52 | 13.97 | 5.83 | 9.19 |
Diluted Net EPS (GAAP) | 5.80 | 13.43 | 20.16 | 4.52 | 7.18 |
Fiscal Year end for Arkema SA falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2,392.63 | 2,531.62 | 2,662.76 | 2,709.26 |
Cost Of Goods | NA | NA | 1,997.21 | 2,071.76 | 2,170.42 |
Gross Profit | NA | NA | 534.40 | 591.00 | 538.85 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 336.31 | 350.02 | 328.46 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 198.09 | 240.98 | 210.39 |
Non-Operating Income | NA | NA | -11.97 | -19.63 | -23.61 |
Interest Expense | NA | NA | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | NA | 186.12 | 221.35 | 186.77 |
Income Taxes | NA | NA | 58.77 | 55.61 | 44.01 |
Minority Interest | NA | NA | 3.27 | 0.00 | 1.07 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 21.54 | 127.34 | 165.74 | 142.76 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 21.54 | 124.08 | 165.74 | 141.69 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 74.07 | 83.21 | 75.04 | 77.65 |
Diluted EPS Before Non-Recurring Items | NA | 1.54 | 2.57 | 3.00 | 2.33 |
Diluted Net EPS (GAAP) | NA | 0.29 | 1.49 | 2.21 | 1.81 |